John Jed Kennedy Power - 01 Mar 2022 Form 4 Insider Report for CONMED Corp (CNMD)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
03 Mar 2022, 17:21:42 UTC
Prior SEC filing
04 Nov 2021
Next SEC filing
07 Mar 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Sarah M. Oliker for John (Jed) Kennedy by Power of Attorney

Key filing fact

John Jed Kennedy Power filed Form 4 for CONMED Corp (CNMD) on 03 Mar 2022.

Key facts

  • This page summarizes John Jed Kennedy Power's Form 4 filing for CONMED Corp (CNMD).
  • 18 reported transactions and 6 derivative rows are listed below.
  • Accepted by SEC: 03 Mar 2022, 17:21.

Change

  • Previous filing in this sequence was filed on 04 Nov 2021.
  • Current net transaction value: -$706,206.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CNMD transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+1,250
Change %
+17%
Price
$0.000000
Shares after
8,625
Date
01 Mar 2022
Ownership
Direct
CNMD transaction

Common Stock

Tax liability

Transaction value
$56,953
Shares
-394
Change %
-4.6%
Price
$144.55
Shares after
8,231
Date
01 Mar 2022
Ownership
Direct
CNMD transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+1,250
Change %
+15%
Price
$0.000000
Shares after
9,481
Date
01 Mar 2022
Ownership
Direct
CNMD transaction

Common Stock

Tax liability

Transaction value
$53,050
Shares
-367
Change %
-3.9%
Price
$144.55
Shares after
9,114
Date
01 Mar 2022
Ownership
Direct
CNMD transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+1,050
Change %
+12%
Price
$0.000000
Shares after
10,164
Date
01 Mar 2022
Ownership
Direct
CNMD transaction

Common Stock

Tax liability

Transaction value
$44,666
Shares
-309
Change %
-3%
Price
$144.55
Shares after
9,855
Date
01 Mar 2022
Ownership
Direct
CNMD transaction

Common Stock

Options Exercise

Transaction value
$209,650
Shares
+5,000
Change %
+51%
Price
$41.93
Shares after
14,855
Date
02 Mar 2022
Ownership
Direct
CNMD transaction

Common Stock

Sale

Transaction value
$727,500
Shares
-5,000
Change %
-34%
Price
$145.50
Shares after
9,855
Date
02 Mar 2022
Ownership
Direct
CNMD transaction

Common Stock

Options Exercise

Transaction value
$18,468
Shares
+308
Change %
+3.1%
Price
$59.96
Shares after
10,163
Date
02 Mar 2022
Ownership
Direct
CNMD transaction

Common Stock

Sale

Transaction value
$44,814
Shares
-308
Change %
-3%
Price
$145.50
Shares after
9,855
Date
02 Mar 2022
Ownership
Direct
CNMD transaction

Common Stock

Options Exercise

Transaction value
$8,664
Shares
+110
Change %
+1.1%
Price
$78.76
Shares after
9,965
Date
02 Mar 2022
Ownership
Direct
CNMD transaction

Common Stock

Sale

Transaction value
$16,005
Shares
-110
Change %
-1.1%
Price
$145.50
Shares after
9,855
Date
02 Mar 2022
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CNMD transaction Derivative

Rsus (restricted Stock Units)

Options Exercise

Transaction value
$0
Shares
-1,250
Change %
-50%
Price
$0.000000
Shares after
1,250
Date
01 Mar 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,250
Exercise price
$0.000000
Footnotes
F1
CNMD transaction Derivative

Rsus (restricted Stock Units)

Options Exercise

Transaction value
$0
Shares
-1,250
Change %
-33%
Price
$0.000000
Shares after
2,500
Date
01 Mar 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,250
Exercise price
$0.000000
Footnotes
F1
CNMD transaction Derivative

Rsus (restricted Stock Units)

Options Exercise

Transaction value
$0
Shares
-1,050
Change %
-25%
Price
$0.000000
Shares after
3,150
Date
01 Mar 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,050
Exercise price
$0.000000
Footnotes
F1
CNMD transaction Derivative

Options To Purchase Common Stock

Options Exercise

Transaction value
$0
Shares
-5,000
Change %
-100%
Price
$0.000000*
Shares after
0
Date
02 Mar 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,000
Exercise price
$41.93
Footnotes
F2
CNMD transaction Derivative

Options To Purchase Common Stock

Options Exercise

Transaction value
$0
Shares
-308
Change %
-2.9%
Price
$0.000000
Shares after
10,492
Date
02 Mar 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
308
Exercise price
$59.96
Footnotes
F2
CNMD transaction Derivative

Options To Purchase Common Stock

Options Exercise

Transaction value
$0
Shares
-110
Change %
-1.9%
Price
$0.000000
Shares after
5,590
Date
02 Mar 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
110
Exercise price
$78.76
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.

Footnote F2

The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.

Footnote F3

The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .